Newsletter | February 23, 2021

02.23.21 -- Exscientia And University Of Oxford Partner To Develop Treatments For Alzheimer's Disease

Sponsor

Industry Insights

Single-Use Platforms Accelerate Viral Vaccine Development, Manufacturing

White Paper | By Amélie Boulais, Sartorius Stedim Biotech

Analysts predict the vaccine market could grow at as much as 10.3 percent through 2024 (CAGR). Single-use platforms might be pivotal to meeting that demand.

Intensified Chromatography Strategies

Article | By Josefin Bolik and Oliver Hardick, Cytiva

With a newer toolbox of options to intensify downstream manufacturing operations, it is important to understand what factors should impact decisions regarding the implementation of these solutions.

Most Popular News

• Exscientia And University Of Oxford Partner To Develop Treatments For Alzheimer’s Disease

• HIV Research Yields Potential Drug Target

• IIT Madras Researchers Show The Way To More Effective Drugs To Treat HIV-AIDS

• Revolution Medicines To Participate In Digital RAS-Targeted Drug Discovery Summit

• Praxis Precision Medicines Partners With Ciitizen To Improve Patient-Guided Drug Development

• BeiGene Announces U.S. FDA Acceptance Of sNDA For BRUKINSA (Zanubrutinib)

• Lupin Receives Approval For Droxidopa Capsules

• Jazz Pharmaceuticals Completes Submission Of sNDA For Xywav Oral Solution

• Sygnature Creates Second Integrated Drug Discovery Site At Alderley Park

• Let The Immune Cell See The Virus: Scientists Discover Unique Way To Target Common Virus

• Eurofins Scientific Announces Acquisition Of Beacon Discovery

Life Science Leader Magazine


		Have you heard of Life Science Leader? Check it out today for access to candid interviews with top-tier executives on how they do business.

This website uses cookies to ensure you get the best experience on our website. Learn more